587 related articles for article (PubMed ID: 15809763)
1. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
3. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
[TBL] [Abstract][Full Text] [Related]
5. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
7. Trisomy 3 in renal cell carcinoma.
Renshaw AA; Fletcher JA
Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314
[TBL] [Abstract][Full Text] [Related]
8. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
Lau LC; Tan PH; Chong TW; Foo KT; Yip S
Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
11. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
[TBL] [Abstract][Full Text] [Related]
12. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
14. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
15. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas.
Lubinski J; Hadaczek P; Podolski J; Toloczko A; Sikorski A; McCue P; Druck T; Huebner K
Cancer Res; 1994 Jul; 54(14):3710-3. PubMed ID: 8033088
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
17. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
19. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
[TBL] [Abstract][Full Text] [Related]
20. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
